VCEL FY 2010 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89,000-51.1% YoY

Gross Profit

$55,00061.8% margin

Operating Income

-$18M-20004.5% margin

Net Income

-$18M-19920.2% margin

EPS (Diluted)

$-14.34

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$33M

Total Liabilities

$30M

Stockholders' Equity

$3M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89,000	$182,000	-51.1%
Gross Profit	$55,000	$70,000	-21.4%
Operating Income	-$18M	-$16M	-10.1%
Net Income	-$18M	-$16M	-11.2%